One of the key ways in which Matt’s Promise stays committed to its mission of finding a cure for Duchenne Muscular Dystrophy is through select funding of promising treatments and research. Since November 2004 we have supported our sister organization, Charley’s Fund in directing over $30 million into medical research to expedite the development of treatments for Duchenne muscular dystrophy. Initially the focus was translational research – research that moves the science from the laboratory into human clinical trials. We are pleased to report that our efforts are helping to now also fund clinical research. This is a clear indication that hopeful therapies are moving through the drug development pipeline. Through innovative partnerships with biotechnology companies and clinicians, we are having a clear and measurable impact on the speed of drug development for Duchenne muscular dystrophy. For further details, please click on each therapeutic strategy.